Mary Beth Son, MD
Clinical Chief, Division of Immunology; Section Chief, Rheumatology Program; Director, Samara Jan Turkel Clinical Center; Director, Services and Outreach
Associate Professor of Pediatrics, Harvard Medical School
Image
Mary Beth Son, MD
Clinical Chief, Division of Immunology; Section Chief, Rheumatology Program; Director, Samara Jan Turkel Clinical Center; Director, Services and Outreach
Associate Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
University of Massachusetts Medical School
2001
Worcester
MA
Internship
Boston Combined Residency Program (BCRP)
2002
Boston
MA
Residency
Boston Combined Residency Program (BCRP)
2004
Boston
MA
Fellowship
Pediatric Rheumatology
Boston Children's Hospital
2008
Boston
MA
Certifications
American Board of Pediatrics (Rheumatology)
Publications
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. View Abstract
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. View Abstract
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. View Abstract
Multicenter Study of Associations Between Area-Level Child Opportunity, Initial Disease Severity, and Outcomes Among Children with Lupus. View Abstract
Community-engaged curriculum development using racial justice and biomedical lenses to address COVID-19 vaccine hesitancy in black individuals with rheumatologic conditions. View Abstract
Universal health-related social needs screening in a paediatric rheumatology clinic. View Abstract
When Blurry Vision Clouds the Bigger Picture. View Abstract
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. View Abstract
Features of hyperinflammation link the biology of Epstein-Barr virus infection and cytokine storm syndromes. View Abstract
Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. View Abstract
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. View Abstract
Kawasaki disease: contemporary perspectives. View Abstract
Community-engaged randomised controlled trial to disseminate COVID-19 vaccine-related information and increase uptake among Black individuals in two US cities with rheumatic conditions. View Abstract
Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease. View Abstract
Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus. View Abstract
Racial and Ethnic Composition of Populations Served by Freestanding Children's Hospitals and Disparities in Outcomes of Pediatric Lupus. View Abstract
The RECOVERY trial of PIMS-TS: important lessons from the pandemic. View Abstract
Updated Case Definition of MIS-C and Implications for Clinical Care. View Abstract
Underutilization of ambulatory blood pressure monitoring in locally and nationally representative samples of patients with childhood-onset systemic lupus erythematosus. View Abstract
Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. View Abstract
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. View Abstract
A case of neonatal sweet syndrome associated with mevalonate kinase deficiency. View Abstract
Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. View Abstract
Understanding Stakeholders' Perspectives to Increase COVID-19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions. View Abstract
Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective study. View Abstract
Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children. View Abstract
Immunomodulatory Therapy for MIS-C. View Abstract
Health Equity Implications of Missing Data Among Youths With Childhood-Onset Systemic Lupus Erythematosus: A Proof-of-Concept Study in the Childhood Arthritis and Rheumatology Research Alliance Registry. View Abstract
Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. View Abstract
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children. View Abstract
Failure of Risk Prediction Modeling for IVIG Resistance in Kawasaki Disease. View Abstract
MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children. View Abstract
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation. View Abstract
Clinical Course Associated with Aseptic Meningitis Induced by Intravenous Immunoglobulin for the Treatment of Multisystem Inflammatory Syndrome in Children. View Abstract
A New Definition for Multisystem Inflammatory Syndrome in Children. View Abstract
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective. View Abstract
Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. View Abstract
The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. View Abstract
Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry. View Abstract
SARS-CoV-2-Related Mitigation Measures and Insights Into Kawasaki Disease. View Abstract
Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children. View Abstract
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study. View Abstract
SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children. View Abstract
Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis and Rheumatology Research Alliance Registry. View Abstract
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract
Pediatric EVALI in the Age of COVID-19/MIS-C: Diagnostic Considerations. View Abstract
Racial Disparities in Renal Outcomes Over Time Among Hospitalized Children With Systemic Lupus Erythematosus. View Abstract
Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies. View Abstract
Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children. View Abstract
New-onset hypogammaglobulinaemia and infectious complications associated with rituximab use in childhood-onset rheumatic diseases. View Abstract
Insurance Delays in Initiation of Tumor Necrosis Factor Inhibitors in Children With Juvenile Idiopathic Arthritis. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. View Abstract
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. View Abstract
When vaccine adverse event reporting generates hope, not fear. View Abstract
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. View Abstract
Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA. View Abstract
An integrated framework for identifying clinical-laboratory indicators for novel pandemics: COVID-19 and MIS-C. View Abstract
An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. View Abstract
Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I/IIa Trial. View Abstract
Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. View Abstract
Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. View Abstract
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents. View Abstract
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. View Abstract
Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis. View Abstract
Therapy for Multisystem Inflammatory Syndrome in Children. Reply. View Abstract
COVID-19 in Pediatrics. View Abstract
Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study. View Abstract
Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). View Abstract
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. View Abstract
Reply. View Abstract
Patient experiences and strategies for coping with SLE: A qualitative study. View Abstract
Assessing preparation for care transition among adolescents with rheumatologic disease: a single-center assessment with patient survey. View Abstract
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. View Abstract
Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C. View Abstract
Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. View Abstract
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. View Abstract
Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. View Abstract
Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. View Abstract
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. View Abstract
Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. View Abstract
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. View Abstract
Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES). View Abstract
Early Features of Progressive Hemifacial Atrophy-Clinical and Imaging Findings. View Abstract
High-Throughput Screening of Kawasaki Disease Sera for Antiviral Antibodies. View Abstract
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. View Abstract
Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. View Abstract
Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. View Abstract
Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. View Abstract
Chronic chest pain: Where is the pathology? View Abstract
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. View Abstract
Pediatric inflammatory syndrome temporally related to covid-19. View Abstract
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. View Abstract
Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. View Abstract
Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses. View Abstract
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. View Abstract
Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. View Abstract
A Case Report of Takayasu's Arteritis and Ulcerative Colitis in a Pediatric Patient with Chronic Recurrent Multifocal Osteomyelitis Successfully Treated with Infliximab: Diagnostic Clues in Disease Associations and Immune Dysregulation. View Abstract
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. View Abstract
Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. View Abstract
Kawasaki Disease. View Abstract
Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. View Abstract
Evidence-based decision support for pediatric rheumatology reduces diagnostic errors. View Abstract
Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. View Abstract
The presentation and management of granulomatosis with polyangiitis (Wegener's Granulomatosis) in the pediatric airway. View Abstract
Laryngeal sarcoidosis: presentation and management in the pediatric population. View Abstract
Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital. View Abstract
A85: effect of childhood-onset systemic lupus erythematosus on linear height and body mass index. View Abstract
Outcomes in hospitalized pediatric patients with systemic lupus erythematosus. View Abstract
Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study. View Abstract
Kawasaki disease. View Abstract
Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies. View Abstract
Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. View Abstract
Management of Kawasaki disease: corticosteroids revisited. View Abstract
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. View Abstract
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. View Abstract
Musculoskeletal causes of pediatric chest pain. View Abstract
Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis. View Abstract
Kawasaki Disease View Abstract
Kawasaki Disease View Abstract
Pocket Pediatrics View Abstract
Juvenile Arthritis View Abstract
Essentials of Emergency Medicine View Abstract
Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. View Abstract
The Boston Marathon Study: a novel approach to research during residency. View Abstract
Locations